[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350577-105":59,"doc-detail-350577-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","triple-tracer-pet-18f-fdg-68ga-dotanoc-68ga-fapi-maps-inter-and-intra-lesional-heterogeneity-in-metastatic-high-grade-neuroendocrine-neoplasms","Triple-tracer PET (18F-FDG, 68Ga-DOTANOC, 68Ga-FAPI) maps inter- and intra-lesional heterogeneity in metastatic high-grade neuroendocrine neoplasms","","A pilot study assessed the diagnostic performance of a triple-tracer PET/CT protocol in 13 patients with advanced, high-grade neuroendocrine neoplasms (Ki-67 > 40%). Imaging with [18F] FDG, [68Ga] Ga-DOTANOC, and [68Ga] Ga-FAPI-04 occurred within one week to capture complementary biology. Across 92 metastatic lesions (hepatic, osseous, and nodal), uptake varied significantly by tracer, revealing marked inter- and intra-patient heterogeneity. The combined approach improved lesion characterization, reduced false negatives, and uncovered heterogeneity that single-tracer imaging could underestimate, supporting feasibility for future multitracer theranostic strategies.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/triple-tracer-pet-18f-fdg-68ga-dotanoc-68ga-fapi-maps-inter-and-intra-lesional-heterogeneity-in-metastatic-high-grade-neuroendocrine-neoplasms/350577/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/triple-tracer-pet-18f-fdg-68ga-dotanoc-68ga-fapi-maps-inter-and-intra-lesional-heterogeneity-in-metastatic-high-grade-neuroendocrine-neoplasms/350577.png","ImageObject",300,407,{"name":92,"@type":93},"Blitz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What was the purpose of the triple-tracer PET/CT protocol in this study?","Question",{"text":113,"@type":114},"To evaluate whether combining [18F] FDG, [68Ga] Ga-DOTANOC, and [68Ga] Ga-FAPI-04 improves assessment of metastatic high-grade neuroendocrine neoplasms by capturing complementary tumor biology and heterogeneity.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How many metastatic lesions and what types were analyzed?",{"text":118,"@type":114},"Ninety-two metastatic lesions were analyzed, including 29 hepatic, 36 osseous, and 27 nodal lesions.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the study find about tracer uptake patterns?",{"text":122,"@type":114},"Tracer uptake differed by site and lesion type: the liver showed the highest [18F] FDG uptake, bone metastases were predominantly [68Ga] Ga-FAPI-avid, and lymph nodes demonstrated mixed avidity across tracers.",{"name":124,"@type":111,"acceptedAnswer":125},"Why are larger prospective studies recommended?",{"text":126,"@type":114},"Because the sample size was limited and statistical power was constrained, larger prospective studies are needed to validate findings and refine patient selection for multitracer imaging or future cocktail therapy strategies.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},350577,1790148109,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":46,"preview_page_count":19,"preview_urls":149},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nTriple-tracer PET ( 18F-FDG, 68 GaDOTANOC, 68 Ga-FAPI) maps interand intra-lesional heterogeneity in metastatic high-grade neuroendocrine neoplasms  \nPrathap Jayachandra Hosahalli1􀀍, S. P. Somashekar2, D. N. Bhoomika3, B. R. Abhijit4, Vishwanath Joshi9, Prashanth Ramachandra Guthlu5, Rajkumar Krishnappa5,  \nMita Kumarswamy Kallur5, Palak Wadhwa6, K. R. Ashwin2, C. Rohit Kumar2, Sai Vivek7, Suva Lakshmi1, Prajwal Rajaghatta Kumaraswamy8 & B. Shameer Ahmed1  \nThis pilot study evaluated the diagnostic performance of a triple-tracer PET/CT protocol in 13 patients with advanced, high-grade neuroendocrine neoplasms (NENs; Ki-67 > 40%) . NENs are characterized by biological heterogeneity and variable tracer avidity, complicating accurate staging and therapy selection. Each patient underwent imaging with [18F] FDG (metabolic activity),[68Ga] Ga-DOTANOC (somatostatin receptor expression), and [68Ga] Ga-FAPI-04 (fibroblast activation) within one week, enabling complementary biological assessment. A total of 92 metastatic lesions were analyzed (29 hepatic, 36 osseous, 27 nodal) . In the liver,[18F] FDG demonstrated the highest uptake (SUVmax  \n18.6 ± 5.3) compared with [68Ga] Ga-FAPI (12.3 ± 3.5) and [68Ga] Ga-DOTANOC (7.8 ± 2.6) . Bone metastases were predominantly [68Ga] Ga-FAPI-avid (SUVmax 9.1 ± 3.0), with 23% detected by [68Ga] Ga-FAPI. Lymph nodes exhibited mixed avidity ([18F] FDG 10.2 ± 4.3; [68Ga] Ga-FAPI 7.0 ± 2.7; [68Ga] Ga-DOTANOC 5.2 ± 3.0). Marked inter-and intra-patient heterogeneity was observed across tracers. The combined protocol improved lesion characterization, reduced false negatives, and revealed heterogeneity that would have been underestimated by single-tracer imaging. These findings demonstrate the feasibility and potential clinical utility of integrating [18F] FDG,[68Ga] Ga-DOTANOC and [68Ga] Ga-FAPI PET in high-grade NENs, providing a more comprehensive theranostics roadmap. Given the limited sample size and statistical power, larger prospective studies are warranted to validate these preliminary observations and refine patient selection for multitracer imaging or future“cocktail” therapy strategies.  \nKeywords Neuroendocrine neoplasms, FDG PET/CT, DOTANOC, FAPI, Tumor heterogeneity, Stroma, High-grade NEN, Theranostics, Radioligand cocktail therapy  \nNeuroendocrine neoplasms (NENs) are uncommon malignancies that most often arise in the gastrointestinal tract and lungs. Their incidence has steadily increased worldwide in recent years. Comprehensive populationlevel studies remain scarce, particularly outside Western countries, leaving important gaps in epidemiological and clinical characterization1. NENs represent a heterogeneous group of tumors originating from diverse anatomical sites and are broadly classified into well-differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs)2,3. The reported incidence of NETs is approximately 3.6 per 100,000 annually in Western countries, with a rising trend over recent decades4. In India lower incidence rate of 2 per 100,000 annually are reported. Also, NET have a different clinicopathological profile compared  \n1Dept of Nuclear Medicine, PET/CT & Theranostics, Aster Whitefield Hospital, Bangalore, India. 2Dept of Surgical Oncology, Aster Whitefield Hospital, Bangalore, India. 3Senior Resident, Bangalore Medical College and Research Institute, Bangalore, India. 4Dept of Medical Gastroenterologist, Aster Whitefield, Bangaluru, India. 5Dept of Nuclear Medicine, HCG Hospitals, Bengaluru, India. 6United Imaging Healthcare, New Delhi, India. 7Dept of Medical Oncology, Aster Whitefield, Bangalore, India. 8Department of General Surgery, Hassan Institute of Medical Sciences, Hassan, India. 9Dept of Radiology, Aster Whitefield Hospital, Bangalore, India. 􀀍 email: [drprathaphj@gmail.com](drprathaphj@gmail.com)  \nto those in Western countries. Very few and lim","cbCaivTOrmxrGzVR","https://ap.wps.com/l/cbCaivTOrmxrGzVR","pdf",1336154,"English","# Introduction\n## Neuroendocrine neoplasms and clinical heterogeneity\n## Imaging tracers and PET/CT rationale\n# Methods and pilot study design\n## Triple-tracer imaging protocol and patient cohort\n# Results\n## Lesion distribution and tracer uptake patterns\n## Inter- and intra-lesional heterogeneity\n# Discussion\n## Clinical implications for staging and therapy planning\n## Limitations and need for larger prospective studies","[{\"question\":\"What was the purpose of the triple-tracer PET/CT protocol in this study?\",\"answer\":\"To evaluate whether combining [18F] FDG, [68Ga] Ga-DOTANOC, and [68Ga] Ga-FAPI-04 improves assessment of metastatic high-grade neuroendocrine neoplasms by capturing complementary tumor biology and heterogeneity.\"},{\"question\":\"How many metastatic lesions and what types were analyzed?\",\"answer\":\"Ninety-two metastatic lesions were analyzed, including 29 hepatic, 36 osseous, and 27 nodal lesions.\"},{\"question\":\"What did the study find about tracer uptake patterns?\",\"answer\":\"Tracer uptake differed by site and lesion type: the liver showed the highest [18F] FDG uptake, bone metastases were predominantly [68Ga] Ga-FAPI-avid, and lymph nodes demonstrated mixed avidity across tracers.\"},{\"question\":\"Why are larger prospective studies recommended?\",\"answer\":\"Because the sample size was limited and statistical power was constrained, larger prospective studies are needed to validate findings and refine patient selection for multitracer imaging or future cocktail therapy strategies.\"}]","Triple-tracer PET (18F-FDG, 68Ga-DOTANOC, 68Ga-FAPI) maps inter- and intra-lesional heterogeneity in metastatic high-grade neuroendocrine neoplasms | PDF",1790089678,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbaefb5e6fcd2fa263737e4e3bf6a2f3.webp",983,1291,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae07b3126a0aad052caa9293ba4c847d.webp",982,1290,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e5c75931edc0ab879df06e5cf6bc008.webp",981,1289,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c13f652b72a7cb6b01049b48b7c0a163.webp",980,1287]